Free Trial
OTCMKTS:OMBP

Omni Bio Pharmaceutical (OMBP) Stock Price, News & Analysis

$0.0010 0.00 (0.00%)
As of 08/18/2020

About Omni Bio Pharmaceutical Stock (OTCMKTS:OMBP)

Key Stats

Today's Range
$0.0010
$0.0010
50-Day Range
N/A
52-Week Range
$0.00
$0.04
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Omni Bio Pharmaceutical, Inc. operates as a biopharmaceutical company in the United States. It holds a license to use patent for the treatment of diabetes using plasma-derived alpha-1 antitrypsin (p-AAT), a protein that is purified from human blood. The company also holds licenses for the use of patents and patent applications covering the use of p-AAT in the treatment of cellular transplantation and graft rejection, radiation protection, bacterial and viral diseases, myocardial remodeling, and inflammatory bowel disease indications. In addition, it holds licenses for patent applications covering compositions of various Fc-AAT constructs. Omni Bio Pharmaceutical, Inc. was founded in 2006 and is headquartered in Fort Collins, Colorado.

Receive OMBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Omni Bio Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

OMBP Stock News Headlines

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd Class A
Elon Warns “America Is Broke”. Trump’s Plan Inside.
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history. Now, he's sounding the alarm about America's $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are...
Shanxi Jinbo Bio pharmaceutical Co Ltd 832982
Sinopep Allsino Bio Pharmaceutical Co Ltd Class A
See More Headlines

OMBP Stock Analysis - Frequently Asked Questions

Omni Bio Pharmaceutical's stock was trading at $0.0010 at the start of the year. Since then, OMBP shares have increased by 0.0% and is now trading at $0.0010.
View the best growth stocks for 2025 here
.

Shares of OMBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Omni Bio Pharmaceutical investors own include Alumina (AWCMY), Xenon Pharmaceuticals (XENE), Yamana Gold (AUY), Asensus Surgical (ASXC), Preferred Apartment Communities (APTS), Ally Financial (ALLY) and Apartment Income REIT (AIRC).

Company Calendar

Today
5/10/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:OMBP
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:OMBP) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners